The invention concerns compounds which inhibit MEK and which have activity as anti-neoplastic agents. These compounds include N-substituted-3-hydroxy-5-arylamino-isothiazole-4-carboxamidines. Also included are the tautomeric isothiazol-3(2H)-ones.

 
Web www.patentalert.com

< Identification of a JAK2 mutation in Polycythemia Vera

> Substituted nitrogen-containing heterobicycles, the preparation thereof and their use as pharmaceutical compositions
~ 00467